See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Invesco QQQ (QQQ) - free report >>
SPDR S&P 500 ETF (SPY) - free report >>
SPDR Dow Jones Industrial Average ETF (DIA) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Invesco QQQ (QQQ) - free report >>
SPDR S&P 500 ETF (SPY) - free report >>
SPDR Dow Jones Industrial Average ETF (DIA) - free report >>
Image: Bigstock
Bank and Biotech: 2 ETFs to Watch on Outsized Volume
In the last trading session, U.S. stocks saw mixed trading due to lack of new information from the Fed minutes. Among the top ETFs, investors saw (SPY - Free Report) and (DIA - Free Report) gain 0.1%, and (QQQ - Free Report) move lower by 0.1% on the day.
Two more specialized ETFs are worth noting as both saw trading volume that was far outside of normal. In fact, both these funds experienced volume levels that were more than double their average for the most recent trading session. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra-interest continues:
(IAT - Free Report) : Volume 5.82 times average
This bank ETF was in the spotlight yesterday as more than 826,000 shares moved hands compared with an average of roughly 150,000 shares a day. We also saw some price movement as IAT lost nearly 0.06% in the last session.
The movement can largely be the cause of rate hike speculations in December that would bolster bank margins and may have a big impact on the sector’s stocks like what we find in this ETF portfolio. IAT was up 0.4% in the past one month and has a Zacks ETF Rank of 3 or ‘Hold’ rating with a High risk outlook.
(BBH - Free Report) : Volume 3.54 times average
This biotech ETF has also been hogging the limelight as around 237,000 shares moved hands on October 12. This compares with an average trading day of around 69,000 shares and came as BBH shed 2.1% in the session.
The big move was largely the result of a crash in share price of Genomic sequencing company Illumina following its slashed revenue guidance. In the past one-month period, BBH was down 7.3% and has a Zacks ETF Rank of 3 with a High risk outlook.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>